Journal
NATURE GENETICS
Volume 48, Issue 11, Pages 1425-1429Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ng.3675
Keywords
-
Categories
Funding
- US National Institutes of Health [U19AI067152, AR043274, R01NS057756, U24NS051869]
- Swedish Research Council
- European Research Council [242551-ImmunoSwitch]
- EURO-PADnet grant [201549]
- CETOCOEN PLUS
- Fondazione C. Golgi, Brescia, Italy
- Stockholm County Council
- Karolinska Institutet
- Nordic Center of Excellence in Disease Genetics
- Yale Center for Human Genetics and Genomics
- Yale Program on Neurogenetics
Ask authors/readers for more resources
Selective immunoglobulin A deficiency (IgAD) is the most common p rimary immunodeficiency in Europeans. Our genome-wide association study (GWAS) meta-analysis of 1,635 patients with IgAD and 4,852 controls identified four new significant (P < 5 x 10(-8)) loci and association with a rare IFIH1 variant (p.11e923Val). Peak new variants (PVT1, P = 4.3 x 10(-11); ATG13-AMBRA1, P = 6.7 x 10(-10); AHI1, P = 8.4 x 10(-10); CLEC16A, P = 1.4 x 10(-9)) overlapped with autoimmune markers (3/4) and correlated with 21 putative regulatory variants, including expression quantitative trait loci (eQTLs) for AHI1 and DEXI and DNase hypersensitivity sites in FOXP3(+) regulatory T cells. Pathway analysis of the meta-analysis results showed striking association with the KEGG pathway for IgA production (pathway P < 0.0001), with 22 of the 30 annotated pathway genes containing at least one variant with P <= 0.05 in the IgAD meta-analysis. These data suggest that a complex network of genetic effects, including genes known to influence the biology of IgA production, contributes to IgAD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available